Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-004466·Cytosorbents Corp
Schedule 13G ownership disclosure
CYTOSORBENTS CORP
Common Stock, par value $0.001 per share · CUSIP: 23283X206
Event date: 2025-01-13
- Filing-level shares
- 3,998,867.00
- Percent of class
- 6.56%
- Thomas A. Satterfield, Jr.
Shares: 3,998,867.00 · Class: 6.56%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-004466
- Form type
- SCHEDULE 13G
- Filer
- Cytosorbents Corp
- CIK
- CIK 1175151
- Filed
- Jan 17, 2025
- Reporting period
- Jan 13, 2025
- Description
- Schedule 13G beneficial ownership